1. Introduction

Biotechnology-assisted reproduction law in Russia governs the use of modern medical and biological technologies to help individuals and couples overcome infertility and achieve parenthood.

Assisted reproductive technologies (ART) involve medical procedures in which fertilisation or early embryo development takes place outside the woman's body, or reproductive material is used to facilitate conception.

The principal technologies include:

In-vitro fertilisation (IVF).

Artificial insemination.

Intracytoplasmic sperm injection (ICSI).

Donor sperm and egg programmes.

Embryo donation.

Cryopreservation of sperm, eggs and embryos.

Preimplantation genetic testing.

Gestational surrogacy.

Posthumous use of reproductive material.

Embryo implantation and reproductive tissue preservation.

Russia recognises assisted reproduction as a legitimate form of infertility treatment. However, the law also regulates informed consent, medical safety, parentage, reproductive autonomy, donor confidentiality and the rights of children born through these procedures.

The central legislative provision is Article 55 of Federal Law No. 323-FZ of 21 November 2011, concerning the protection of citizens' health.

minzdrav.gov.ru+1

2. Constitutional and Legislative Framework

Russian assisted reproduction law is based on several interconnected legal instruments.

The legal framework combines medical regulation with family law and civil liability.

A. Constitution of the Russian Federation

The Constitution provides the broader foundation for reproductive rights.

Relevant constitutional principles include:

Article 19: Equality before the law.

Article 21: Protection of human dignity.

Article 23: Privacy and personal and family secrets.

Article 38: Protection of family, motherhood and childhood.

Article 41: Right to health protection and medical assistance.

These provisions are relevant when courts consider reproductive autonomy, medical confidentiality, discrimination and the legal protection of children.

B. Federal Law No. 323-FZ of 2011

Article 55 is the principal statutory provision concerning assisted reproductive technologies.

It defines ART as methods of infertility treatment in which some or all stages of conception and early embryo development occur outside the maternal organism.

The provision expressly recognises the use of:

Donated reproductive cells.

Cryopreserved reproductive cells.

Reproductive tissues.

Cryopreserved embryos.

Surrogacy.

It also establishes the requirement for informed voluntary consent and prohibits sex selection except where necessary to prevent inheritance of sex-linked diseases.

minzdrav.gov.ru+1

3. Eligibility for Assisted Reproductive Technologies

Article 55 distinguishes ordinary ART treatment from surrogacy.

A. Married couples

A married couple may access IVF and other authorised reproductive procedures with mutual informed and voluntary consent.

Both spouses should understand:

The medical procedure.

The use of their own or donated reproductive material.

Potential medical complications.

Embryo creation and implantation.

The storage and future use of embryos.

The legal consequences of their consent.

B. Unmarried couples

Unmarried men and women may generally access ART with mutual informed consent.

However, following the 2022 amendments, unmarried couples cannot use the Russian statutory surrogacy arrangement.

C. Single women

Russian law recognises the right of a single woman to use ART with her informed voluntary consent.

A single woman may also use surrogacy if she satisfies the statutory conditions, including the requirement that her own reproductive cells are used and pregnancy is medically impossible.

D. Single men

The position of single men is different.

Article 55 does not provide single men with an unconditional statutory right to enter into a surrogacy arrangement. The Constitutional Court addressed this issue in 2021, discussed below.

4. IVF and Other Biotechnology Procedures

Неудачное ЭКО: что делать дальше?

Tiêm tinh trùng vào bào tương của noãn (ICSI): Giải pháp cho các cặp vợ chồng vô sinh do yếu tố nam | Vinmec

Frozen Embryo Transfer in Ireland | Thérapie Fertility

10

Russian law recognises several medically assisted reproductive procedures.

A. In-vitro fertilisation (IVF)

IVF involves fertilising an egg with sperm in a laboratory and subsequently transferring the resulting embryo into the woman's uterus.

The procedure generally involves:

Medical assessment.

Ovarian stimulation.

Collection of eggs.

Preparation of sperm.

Fertilisation.

Embryo cultivation.

Embryo transfer.

Pregnancy monitoring.

Under Ministry of Health Order No. 803n of 31 July 2020, IVF is the basic ART programme. The order regulates the procedure, medical indications, contraindications and restrictions.

ronc.ru+1

B. Intracytoplasmic sperm injection (ICSI)

ICSI involves introducing an individual sperm cell directly into an egg.

It is particularly relevant where male-factor infertility makes conventional fertilisation difficult.

Russian law permits ICSI as part of authorised ART treatment.

C. Artificial insemination

Artificial insemination involves introducing prepared sperm into the reproductive tract without conventional sexual intercourse.

It may involve the partner's sperm or donated sperm.

The procedure must comply with medical requirements and informed-consent rules.

D. Cryopreservation

Cryopreservation involves preserving reproductive material at extremely low temperatures for possible future use.

Russian law expressly recognises the right to preserve:

Sperm cells.

Oocytes.

Reproductive tissues.

Embryos.

Article 55(5) of Federal Law No. 323-FZ recognises cryopreservation and storage at personal expense or through other legally permitted funding arrangements.

A significant legal issue arises when a couple separates, divorces or one partner dies before stored embryos are used. Consent documents and the terms governing storage and future use become particularly important.

E. Donor gametes and embryos

Russian law permits the use of donated reproductive cells and embryos.

Article 55(7) establishes donor eligibility requirements, including:

Age between 18 and 35 years.

Physical and mental health.

Medical and genetic examination.

Under Article 55(8), recipients have a right to receive specified information concerning the donor's medical and genetic examination results, race, nationality and external characteristics.

The donor's genetic contribution does not automatically create legal parenthood.

5. Legal Regulation of Surrogacy in Russia

Surrogacy is one of the most legally significant aspects of Russian reproductive biotechnology law.

It involves a woman carrying and giving birth to a child following the transfer of an embryo under a surrogacy agreement.

Article 55(9) of Federal Law No. 323-FZ provides the statutory foundation.

A. Conditions for surrogacy

Under the post-2022 framework, the arrangement is generally available to:

A married heterosexual couple whose genetic cells are used in fertilisation and for whom pregnancy and childbirth are medically impossible.

A single woman whose own reproductive cells are used and for whom pregnancy and childbirth are medically impossible.

At least one intended parent, or the single intended mother, must be a Russian citizen.

B. Qualifications of a surrogate mother

Article 55(10) establishes the following conditions:

These requirements are designed to protect the surrogate mother and ensure that the arrangement meets statutory conditions.

C. Surrogacy agreement

The agreement is a central document in the relationship between intended parents and the surrogate mother.

It should address:

Medical responsibilities.

Financial compensation.

Pregnancy-related expenses.

Medical examinations.

Confidentiality.

Delivery arrangements.

Registration of the child's birth.

Allocation of responsibilities after childbirth.

Dispute resolution.

Contingencies involving pregnancy complications or multiple births.

The agreement must be interpreted together with Article 55 of Law No. 323-FZ and Article 51 of the Family Code.

Important: A surrogacy agreement does not automatically make the intended parents the child's legally registered parents. The statutory registration requirements and the surrogate mother's consent remain important.

6. Surrogacy Restrictions Introduced in 2022

Major legislative change

Federal Law No. 538-FZ of 19 December 2022 significantly changed the Russian surrogacy system.

Before the amendment, Russia was known for allowing comparatively broad access to commercial surrogacy, including arrangements involving foreign intended parents.

The amended legislation restricts access to surrogacy.

Principal restrictions

1. Foreign intended parents

Foreign citizens and stateless persons are generally prohibited from using surrogacy services in Russia under the amended framework.

2. Russian citizenship requirement

At least one intended parent must be a Russian citizen, or the intended single mother must be a Russian citizen.

3. Registered marriage

An intended couple must have a legally registered marriage. Unmarried couples cannot use the statutory surrogacy arrangement.

4. Russian surrogate mother

The surrogate mother must be a Russian citizen.

5. Citizenship of the child

The legislation provides for Russian citizenship by birth for children born in Russia through qualifying surrogacy arrangements.

6. Transitional protection

Special transitional provisions apply to certain arrangements where the surrogate mother was already pregnant or had given birth under an earlier agreement when the amendments took effect.

These changes are reflected in the amended Article 55 and Federal Law No. 538-FZ.

ГАРАНТ+2

7. Legal Parentage and Registration of Children

The legal parentage of children born through assisted reproduction is governed principally by Articles 51 and 52 of the Russian Family Code.

A. IVF parentage

Under Article 51(4), married persons who have given written consent to artificial insemination or embryo implantation are recorded as the child's parents.

This means that legal parentage is not necessarily determined exclusively by genetic connection.

B. Donor-related parentage

Where donor sperm or eggs are used with the legally required consent, the donor does not acquire parental rights and obligations merely by contributing genetic material.

The legal framework protects the intended parents' parental status.

C. Surrogate mother's consent

Under Article 51(4), a married couple who have consented in writing to embryo implantation into another woman may be registered as the child's parents only with the consent of the woman who gave birth.

This creates an important distinction between:

Genetic parenthood.

The surrogate mother's status as the woman who gives birth.

Legal parenthood established through registration.

D. Disputes over parentage

Article 52 of the Family Code regulates challenges to parentage.

A spouse who has given legally valid written consent to ART generally cannot challenge paternity merely because artificial insemination or embryo implantation was used.

However, the law does not eliminate every possible ground for challenging a birth registration.

The court must examine the circumstances of consent, including whether it was voluntary, informed, valid at the relevant time and applicable to the use of donor material.

8. Important Russian Case Laws

Russian judicial decisions are particularly important because assisted reproduction creates legal relationships that traditional family law cannot always resolve adequately.

Case 1. Constitutional Court of Russia – Decision No. 30-P of 29 June 2021

Important constitutional precedent

Subject: Surrogacy, single fathers and maternity capital.

Court: Constitutional Court of the Russian Federation.

Legal issue:

Whether a single man who became the legal father of children born through surrogacy could receive maternity capital after subsequently marrying and raising the children with his wife, who adopted them.

Background:

A man had children through a surrogacy arrangement and was recognised as their sole legal father. He subsequently married, and his wife adopted the children.

The family sought maternity capital under the legislation governing state support for families with children.

The legal problem was that the relevant legislation did not adequately accommodate this particular family structure.

Court's decision:

The Constitutional Court found that excluding such a family from maternity capital after the father's marriage and his wife's adoption of the children violated constitutional equality and family-protection principles.

The Court required legislative correction of the legal framework.

Legal principles:

Families formed through assisted reproduction deserve legal protection.

A child's interests should not be disregarded because of the method of birth.

Family-support legislation must account for different lawful family structures.

Legal recognition of parenthood through surrogacy has consequences for social benefits.

Importance: This decision is significant for understanding the relationship between biotechnology, constitutional equality and family-support rights.

Consultant Plus+1

Case 2. Supreme Court of Russia – Plenum Resolution No. 16 of 16 May 2017

Subject: Establishing the origin of children born through assisted reproductive technologies.

Court: Supreme Court of the Russian Federation.

Legal issue:

How should Russian courts resolve disputes concerning children born through artificial insemination, embryo implantation and surrogacy?

Court's legal guidance:

Paragraph 30 explains that married persons who have provided written consent to artificial insemination or embryo implantation are recorded as parents.

The Court also explains that a spouse who consented cannot challenge paternity simply by relying on the fact that ART was used.

However, courts must examine other legally relevant circumstances, including:

Whether consent was voluntary and informed.

Whether consent was withdrawn.

Whether the consent remained valid when the procedure took place.

Whether the spouse consented to donor biological material.

Paragraph 31 deals with surrogacy and the registration of intended parents.

Paragraph 32 addresses the position of reproductive-cell donors.

Legal principle:

The existence of a genetic relationship alone does not determine legal parenthood when the child was conceived through a legally authorised donor programme.

Importance: This is one of the most important judicial guidelines for ART disputes in Russia.

vsrf.ru+2

Case 3. Supreme Court – Civil Case No. 46-КГ19-24, 26 November 2019

Subject: Consent to the use of donor biological material.

Court: Judicial Collegium for Civil Cases of the Supreme Court of the Russian Federation.

Legal issue:

Whether donor reproductive material could lawfully be used in ART treatment without the informed and voluntary consent of both spouses.

Background and legal question:

The dispute concerned the use of donor biological material in reproductive treatment and the legal significance of the spouses' consent.

Court's position:

The Supreme Court emphasised that donor biological material may be used only with the necessary personal, informed and voluntary consent of both spouses.

The Court relied on Article 20 of Federal Law No. 323-FZ, which requires informed voluntary consent before medical intervention.

Legal principles:

Consent must be informed.

Consent must be voluntary.

Consent must cover the relevant reproductive procedure.

Consent to ART cannot automatically be treated as consent to every possible use of donor material.

Importance: This decision is important for medical institutions, fertility clinics and spouses entering donor-assisted reproductive programmes.

legalacts.ru+1

Case 4. Supreme Court – Surrogacy Parentage Principles under Resolution No. 16 (2017), Paragraph 31

Subject: Rights of intended parents and surrogate mothers.

Legal issue:

Whether intended parents can automatically be registered as parents of a child born through surrogacy.

Court's position:

The Supreme Court explained that Article 51(4) of the Family Code requires the surrogate mother's consent before the intended parents can be recorded as the child's parents.

Where the surrogate mother refuses consent, the dispute must be considered by the court in light of the relevant circumstances and the child's interests.

Legal principles:

Genetic connection is relevant but does not independently settle registration.

The surrogate mother's statutory consent is important.

Contractual obligations must be considered alongside family-law rules.

The child's best interests must guide judicial determination.

Importance: This principle prevents surrogacy contracts from being treated as automatically overriding the legal position of the woman who gives birth.

vsrf.ru+1

Case 5. Supreme Court – Resolution No. 16 (2017), Paragraph 32

Subject: Legal status of sperm and egg donors.

Legal issue:

Can a donor claim legal parenthood merely because the donor's genetic material was used to conceive a child?

Court's position:

The Supreme Court clarified that using donor genetic material does not create parental rights and obligations between the donor and the child.

A donor cannot claim parenthood solely on the basis of biological contribution.

Similarly, intended parents cannot ordinarily seek to establish the donor as the child's legal parent merely because donor material was used.

Legal principles:

Genetic contribution and legal parenthood are distinct.

Donors do not automatically acquire parental status.

The legal position of intended parents is protected by the statutory consent framework.

Reproductive donations must be distinguished from ordinary biological parentage.

Importance: This principle is central to donor-assisted IVF, sperm donation, egg donation and embryo donation disputes.

vsrf.ru+1

9. Regulation of Medical Institutions and Fertility Clinics

Russian fertility clinics must comply with medical licensing and healthcare requirements.

Order No. 803n establishes the technical and medical framework for ART.

Important compliance areas include:

A. Medical licensing

Clinics must have the appropriate authorisation to provide relevant medical services.

B. Patient screening

Patients undergo medical assessment to identify infertility, medical risks and contraindications.

C. Laboratory standards

Embryo cultivation, reproductive-cell handling and storage require appropriate medical and laboratory procedures.

D. Medical records

Clinics must maintain relevant patient records, consent documents and treatment information.

E. Donor screening

Donors must satisfy the statutory age, health and medical-genetic examination requirements.

F. Embryo transfer

The standard IVF programme under Order No. 803n generally permits transfer of no more than two embryos, with selective single-embryo transfer indicated in specified medical circumstances.

G. Medical confidentiality

Reproductive treatment information is protected by the medical confidentiality requirements of Article 13 of Federal Law No. 323-FZ.

ronc.ru+2

10. Genetic Testing and Preimplantation Genetic Diagnosis

培養室での生検(Biopsy)の流れは？～PGTにおける実際の手技～ | 浅田レディースクリニック(東京/品川・愛知)

ameblo.jp

Genetic testing is an increasingly important aspect of biotechnology-assisted reproduction.

Preimplantation genetic testing (PGT) can be used to examine embryos for particular genetic or chromosomal abnormalities before implantation.

Its legal implications include:

Prevention of certain inherited diseases.

Genetic privacy.

Protection against discrimination.

Accuracy of laboratory results.

Informed parental consent.

Ethical limits on embryo selection.

Article 55(4) prohibits choosing the sex of a future child through ART, except where this is necessary to avoid inheritance of sex-linked diseases.

Consequently, sex selection for purely personal or social preferences is not permitted.

A distinction must be maintained between medically indicated genetic testing and the use of reproductive biotechnology for non-medical selection.

11. Embryo Ownership, Storage and Disputes

One of the most difficult questions in reproductive biotechnology law concerns the legal status of stored embryos.

Consider a situation in which a married couple creates five embryos through IVF. They use two embryos and store the remaining three.

Later, the couple divorces.

Questions arise:

Can one spouse use the embryos without the other's consent?

Can the embryos be transferred to another clinic?

Can one spouse demand destruction of the embryos?

What happens if one spouse dies?

Can embryos be donated to another couple?

Who pays for continued storage?

Article 55 recognises cryopreservation and storage but does not provide a comprehensive statutory solution for every possible post-divorce or posthumous embryo dispute.

Therefore, the written consent documents, clinic agreements, applicable medical rules and civil-law principles become important.

Legal concern: Human embryos cannot simply be treated as ordinary commercial property. Their use must respect the reproductive autonomy and legally relevant consent of the individuals involved.

12. Posthumous Reproduction in Russia

Posthumous reproduction involves the use of sperm, eggs or embryos after the death of a person whose reproductive material was preserved.

For example:

A man freezes his sperm before undergoing cancer treatment. He subsequently dies. His spouse wishes to use the preserved sperm to conceive a child.

This creates questions concerning:

Whether prior consent authorised posthumous use.

Whether the deceased intended parenthood after death.

The rights of the surviving spouse.

The legal status of the resulting child.

Inheritance rights.

Civil registration of parentage.

Russian legislation does not provide a complete, comprehensive statutory regime for all posthumous ART situations.

Consequently, the exact wording of prior consent, medical documentation, family-law provisions and inheritance rules may become decisive.

It is particularly important not to assume that consent to freezing reproductive material automatically constitutes consent to its use after death.

13. Commercial Surrogacy and Civil Liability

Commercial surrogacy raises significant contractual and ethical issues.

Russian law recognises surrogacy agreements, but contractual freedom is limited by mandatory healthcare and family-law provisions.

A. Contractual disputes

Disputes may involve:

Non-payment of agreed compensation.

Medical expenses.

Breach of confidentiality.

Failure to comply with agreed medical arrangements.

Disagreement over registration of parentage.

Pregnancy complications.

Premature delivery.

Multiple births.

B. Medical negligence

A fertility clinic may face civil liability where negligent treatment causes legally recognised harm.

Examples include:

Improper embryo handling.

Incorrect laboratory identification.

Negligent medical screening.

Unauthorised use of reproductive material.

Improper storage of embryos.

Failure to obtain valid informed consent.

Relevant provisions include Articles 1064 and 1095–1098 of the Russian Civil Code, depending on the nature of the claim and the parties involved.

C. Consumer protection

Where reproductive services fall within the scope of consumer-protection legislation, patients may also rely on applicable provisions of the Law of the Russian Federation No. 2300-I of 7 February 1992 on Consumer Rights Protection.

This may be relevant to defective medical services, inadequate information and contractual disputes.

14. International and Cross-Border Assisted Reproduction

Cross-border reproductive treatment creates conflicts between Russian law and foreign family-law systems.

For example:

A foreign couple previously entered into a surrogacy agreement in Russia.

The child is born in Russia.

The intended parents seek recognition of parenthood in their home country.

Their home country prohibits or restricts surrogacy.

This raises questions about:

Recognition of foreign birth certificates.

Nationality of the child.

Recognition of parental status.

International adoption rules.

Immigration documentation.

Public-policy objections.

Enforcement of surrogacy agreements.

Federal Law No. 538-FZ has substantially restricted the use of Russian surrogacy services by foreign citizens.

However, questions concerning children born under earlier agreements and recognition of pre-existing parentage may require individual examination.

Foreign recognition of Russian parentage is not automatic. It depends on the law of the country in which recognition is sought.

15. Ethical and Human Rights Issues

Assisted reproductive biotechnology raises several important ethical and human-rights concerns in Russia.

A. Protection against exploitation

Surrogate mothers must provide voluntary informed consent. Financial arrangements must not become instruments of coercion or exploitation.

B. Children's best interests

The United Nations Convention on the Rights of the Child provides an important international framework.

Article 3 requires the best interests of the child to be a primary consideration in decisions affecting children.

This principle is particularly relevant to surrogacy disputes, parentage registration and nationality.

C. Genetic privacy

Genetic information may reveal highly personal information about individuals and their biological relatives.

Its collection, processing, storage and disclosure must comply with applicable Russian medical confidentiality and personal-data legislation, including Federal Law No. 152-FZ of 27 July 2006.

16. Major Legal Challenges in Russia

Despite the existence of statutory and judicial rules, several questions remain important.

1. Incomplete regulation of embryos: The legal treatment of stored embryos in divorce, death and disagreements between former partners requires further clarification.

2. Surrogacy parentage: Conflicts can arise between the intended parents' genetic connection and the surrogate mother's statutory position.

3. International recognition: Foreign jurisdictions may refuse to recognise parentage established through Russian surrogacy.

4. Single-parent arrangements: The legal framework does not give single men the same statutory surrogacy access as qualifying single women.

5. Donor identity: The balance between donor confidentiality and the interests of donor-conceived children remains significant.

6. Genetic discrimination: Genetic testing creates risks involving insurance, employment and misuse of personal biological information.

7. Medical accountability: IVF laboratory errors and improper embryo handling can create complicated questions of causation and compensation.

8. Posthumous reproduction: The absence of a comprehensive framework creates uncertainty concerning consent, parentage and inheritance.

17. Important Legislation and Cases: Quick Reference

18. Conclusion

Biotechnology-assisted reproduction law in Russia represents an intersection of medical science, constitutional rights, family law, civil liability and reproductive ethics.

Federal Law No. 323-FZ provides the primary legal foundation for IVF, artificial insemination, donor reproductive material, cryopreservation and surrogacy. The Family Code determines the legal consequences of assisted reproduction, particularly concerning parental registration and challenges to parentage.

The Supreme Court's Resolution No. 16 of 2017 provides important judicial guidance on informed consent, donor status and surrogacy parentage. The Constitutional Court's Decision No. 30-P of 2021 demonstrates that families formed through surrogacy must also be considered within the constitutional framework of equality and family protection.

The 2022 amendments introduced by Federal Law No. 538-FZ significantly restricted international surrogacy and established citizenship and marriage-related eligibility requirements.

Ultimately, the central challenge for Russian biotechnology-assisted reproduction law is to balance reproductive autonomy, medical safety, the dignity of surrogate mothers, genetic privacy and the best interests of children.

19. Official and Research Sources

The following materials are useful for further legal research:

Federal Law No. 323-FZ – Article 55, Russian Ministry of Health.

Federal Law No. 323-FZ – consolidated legislation, 2025 edition.

Federal Law No. 538-FZ of 19 December 2022.

Ministry of Health Order No. 803n of 31 July 2020.

Supreme Court Resolution No. 16 of 16 May 2017.

Constitutional Court Decision No. 30-P of 29 June 2021.

Supreme Court Case No. 46-KG19-24 of 26 November 2019.

Academic note: The Supreme Court's Resolution No. 16 is an authoritative judicial interpretation rather than an individual trial judgment. Decision No. 30-P and Case No. 46-KG19-24 are separate judicial authorities. The discussion above is an educational overview, not an exhaustive list of Russian ART litigation or a substitute for checking the latest consolidated legislation.

I can also prepare a research-paper version with 20–30 Russian judicial decisions, statutory provisions and detailed case-by-case legal analysis on this subject.